Revista gaucha de enfermagem · 2025
Minas Gerais Reference Center for Special Immunobiologicals: clinical and epidemiological profile (2005-2022).
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Oliveira Thaís Moreira, Bragança Ana Luiza Gomes, Alcantara Tatianne Márcia Perdigão de Carvalho, Carvalho Natatia Santana, Ribeiro José Geraldo Leite, Prosdocimi Eduardo Campos, Silva Thales Philipe Rodrigues da, Matozinhos Fernanda Penido
Аннотация
OBJECTIVE: To analyze the clinical and epidemiological profile of remote consultations evaluated by the Reference Center for Special Immunobiologicals of Minas Gerais, Brazil, between 2005 and 2022.
METHOD: Cross-sectional and retrospective study. Data collection was performed by extracting data from the request forms evaluated in virtual consultations. The statistical program Stata® was used for the analysis. Categorical variables were described using absolute and relative frequencies, and continuous variables were described using median and interquartile range.
RESULTS: Of the 84,800 forms evaluated, 32,750 individuals were eligible to receive special immunobiologicals, with 65,521 doses prescribed. Among these individuals, 11,505 (35.1%) were children, 1,943 (6.0%) were adolescents, 12,024 (36.7%) were adults, and 7,278 (22.2%) were people over 60 years of age. There was a predominance of males with white skin color. The prescription of the Pneumococcal 23 vaccine was more prevalent among adolescents, adults, and the elderly (30.8%, 34.9%, and 63.6%, respectively).
CONCLUSION: This study analyzed the clinical and epidemiological profile of patients treated at the Reference Center for Special Immunobiologicals in Minas Gerais over a period of 17 years. The characterization of users and prescribed immunobiologicals made it possible to identify this profile, highlighting the relevance of the service.
METHOD: Cross-sectional and retrospective study. Data collection was performed by extracting data from the request forms evaluated in virtual consultations. The statistical program Stata® was used for the analysis. Categorical variables were described using absolute and relative frequencies, and continuous variables were described using median and interquartile range.
RESULTS: Of the 84,800 forms evaluated, 32,750 individuals were eligible to receive special immunobiologicals, with 65,521 doses prescribed. Among these individuals, 11,505 (35.1%) were children, 1,943 (6.0%) were adolescents, 12,024 (36.7%) were adults, and 7,278 (22.2%) were people over 60 years of age. There was a predominance of males with white skin color. The prescription of the Pneumococcal 23 vaccine was more prevalent among adolescents, adults, and the elderly (30.8%, 34.9%, and 63.6%, respectively).
CONCLUSION: This study analyzed the clinical and epidemiological profile of patients treated at the Reference Center for Special Immunobiologicals in Minas Gerais over a period of 17 years. The characterization of users and prescribed immunobiologicals made it possible to identify this profile, highlighting the relevance of the service.